Mario Gabelli Neogenomics Inc Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $4,942 - $9,779	-700 Reduced 2.24%	30,510 $249,000
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $20,655 - $59,976	1,700 Added 5.76%	31,210 $379,000
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $24,392 - $38,792	-800 Reduced 2.64%	29,510 $1.01 Million
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $4,166 - $5,252	-100 Reduced 0.33%	30,310 $1.46 Million
Q2 2021 Aug 13, 2021	BUY	$36.62 - $51.69 $80,564 - $113,718	2,200 Added 7.8%	30,410 $1.37 Million
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $541,942 - $780,835	-13,040 Reduced 31.61%	28,210 $1.36 Million
Q4 2020 Feb 05, 2021	SELL	$36.08 - $56.47 $220,088 - $344,467	-6,100 Reduced 12.88%	41,250 $2.22 Million
Q3 2020 Nov 06, 2020	SELL	$33.26 - $40.48 $365,860 - $445,279	-11,000 Reduced 18.85%	47,350 $1.75 Million
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $383,486 - $491,356	-15,840 Reduced 21.35%	58,350 $1.81 Million
Q1 2020 May 14, 2020	SELL	$20.5 - $34.53 $503,193 - $847,573	-24,546 Reduced 24.86%	74,190 $2.05 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $145,992 - $229,768	-7,700 Reduced 7.23%	98,736 $2.89 Million
Q3 2019 Nov 01, 2019	SELL	$19.12 - $26.24 $483,716 - $663,845	-25,299 Reduced 19.2%	106,436 $2.04 Million
Q2 2019 Aug 02, 2019	SELL	$19.57 - $24.1 $228,969 - $281,970	-11,700 Reduced 8.16%	131,735 $2.89 Million
Q1 2019 May 02, 2019	SELL	$12.14 - $20.46 $94,692 - $159,588	-7,800 Reduced 5.16%	143,435 $2.94 Million
Q4 2018 Jan 30, 2019	SELL	$11.24 - $18.5 $441,552 - $726,754	-39,284 Reduced 20.62%	151,235 $1.91 Million
Q3 2018 Nov 02, 2018	SELL	$12.5 - $15.38 $62,500 - $76,900	-5,000 Reduced 2.56%	190,519 $2.92 Million
Q2 2018 Aug 10, 2018	SELL	$7.99 - $14.05 $1.17 Million - $2.06 Million	-146,860 Reduced 42.89%	195,519 $2.56 Million
Q1 2018 May 09, 2018	BUY	$7.23 - $8.76 $1.69 Million - $2.05 Million	233,479 Added 214.4%	342,379 $2.79 Million
Q4 2017 Feb 02, 2018	BUY	$8.02 - $11.18 $401,000 - $559,000	50,000 Added 84.89%	108,900 $965,000
Q3 2017 Nov 01, 2017	BUY	$9.11 - $11.26 $536,579 - $663,214	58,900	58,900 $656,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$338 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$241 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$118 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$113 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$112 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account